Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd financial flexibility index. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a Financial Flexibility Index of 0.68x as of September 2025. Free cash flow of CN¥110.89 Million (operating CF CN¥88.11 Million minus capex CN¥22.77 Million) represents 1% of total liabilities (CN¥161.98 Million). See 300357 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Financial flexibility index of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. Historical Financial Flexibility Index trend for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd across 16 annual periods. Check 300357 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Financial Flexibility Index by Year (2009–2024)
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd financial flexibility index by year from 2009 to 2024. Year-by-year free cash flow to debt coverage for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.52x | CN¥380.41 Million | CN¥262.44 Million | CN¥250.30 Million | ▼ -34.3% |
| 2023 | 2.31x | CN¥597.48 Million | CN¥388.32 Million | CN¥258.46 Million | ▼ -28.1% |
| 2022 | 3.22x | CN¥549.02 Million | CN¥360.28 Million | CN¥170.76 Million | ▼ -9.8% |
| 2021 | 3.57x | CN¥482.73 Million | CN¥360.58 Million | CN¥135.36 Million | ▼ -16.3% |
| 2020 | 4.26x | CN¥326.38 Million | CN¥256.22 Million | CN¥76.61 Million | ▼ -2.4% |
| 2019 | 4.36x | CN¥332.75 Million | CN¥232.93 Million | CN¥76.25 Million | ▲ +3.2% |
| 2018 | 4.23x | CN¥264.20 Million | CN¥206.45 Million | CN¥62.47 Million | ▲ +2.6% |
| 2017 | 4.12x | CN¥193.86 Million | CN¥159.13 Million | CN¥47.05 Million | ▲ +7.3% |
| 2016 | 3.84x | CN¥158.70 Million | CN¥122.77 Million | CN¥41.32 Million | ▼ -25.0% |
| 2015 | 5.12x | CN¥146.33 Million | CN¥114.82 Million | CN¥28.57 Million | ▼ -14.5% |
| 2014 | 5.99x | CN¥106.37 Million | CN¥83.70 Million | CN¥17.75 Million | ▼ -4.9% |
| 2013 | 6.30x | CN¥75.83 Million | CN¥58.30 Million | CN¥12.04 Million | ▲ +26.7% |
| 2012 | 4.97x | CN¥48.41 Million | CN¥41.17 Million | CN¥9.73 Million | ▲ +320.8% |
| 2011 | 1.18x | CN¥23.14 Million | CN¥19.15 Million | CN¥19.58 Million | ▼ -5.4% |
| 2010 | 1.25x | CN¥25.10 Million | CN¥14.54 Million | CN¥20.08 Million | ▼ -65.2% |
| 2009 | 3.59x | CN¥34.11 Million | CN¥12.63 Million | CN¥9.49 Million | — |